Le Lézard
Classified in: Health
Subjects: HEALTH, GOVERNMENT CONTRACTS

Nikkiso Cryogenic Services Recommissioned Air Separation Plant in India for Critical Oxygen Supply


TEMECULA, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Nikkiso Cryogenic Industries' Clean Energy & Industrial Gases Group (Group), a subsidiary of Nikkiso Co., Ltd (Japan), is proud to announce they have completed the recommissioning of an Air Separation plant in Patancheru, Hyderabad India. This project was done in coordination with the Telangana government (TEL), and Greenko Foundation (GKO).

Due to the ongoing pandemic crisis in India, the Indian government initiated a directive to restart the operation and LOX production to meet the urgent demands for medical oxygen. GKO has taken the old shut-down Oxygen plant on rental basis from Air Water India Private Limited (AWI) for period of (2) two years.

In May 2021, the Group partnered along with GKO in recommissioning of the plant. Nikkiso Cryogenic Services provided critical technical support and spare parts, including nozzle actuators and vibration components, and Nikkiso Cosmodyne India Pvt. Ltd. provided field service support. Critical components which typically take 12-14 weeks were provided in three days to support this urgent request. By June 22nd, the site was fully operational again.

"We are proud to have played a role in this fight against COVID, and of the technology and teamwork it took to get this facility up and running in such short time," according to Jim Estes, President, Nikkiso Cryogenic Services.

The Group has been instrumental in providing continuous global support for the critical oxygen supply throughout the COVID epidemic.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture engineered cryogenic gas processing equipment and small-scale process plants for the liquefied natural gas (LNG), well services and industrial gas industries. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Cosmodyne and Cryoquip and a commonly-controlled group of approximately 20 operating entities.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:

Anna Quigley
+1.951.383.3314
[email protected]



These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: